• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 16, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

High blood sugar increases pancreatic cancer rate

Bioengineer by Bioengineer
July 24, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Nationwide study finds early detection of hyperglycemia may lower risk

WASHINGTON–High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

An 45,750 deaths (23,800 men and 21,950 women) will occur this year from pancreatic cancer, a disease in which healthy cells in the pancreas stop working correctly and grow out of control. The five-year survival rate for people with pancreatic cancer is only nine percent because the disease is so difficult to diagnose and is often not found until later stages when the cancer has spread from the pancreas to other parts of the body.

“Diabetes is one of the established risk factors for pancreatic cancer,” said the study’s corresponding author, Cheol-Young Park, M.D., Ph.D., of Kangbuk Samsung Hospital in Seoul, Korea. “When we evaluated the pancreatic cancer incidence according to fasting glucose levels using a national cohort database, we found the number of pancreatic cancer cases rose as fasting glucose levels increased. This was true in people who had diabetes as well as those who did not.”

In this nationwide study, researchers evaluated pancreatic cancer incidence in Korea according to blood sugar levels using a national cohort database of more than 25 million patients. They found that as blood sugar levels rose, the rate of pancreatic cancer significantly increased not only in diabetic populations, but also in those with prediabetes or normal range of blood sugar levels.

“Our research implies that early detection of hyperglycemia in health checkups and lifestyle modification to improve glucose profile might offer a critical opportunity for lowering the risk of pancreatic cancer,” Park said.

###

Other authors of the study include: Dong-Hoe Koo of Kangbuk Samsung Hospital, and Kyung-Do Han of The Catholic University of Korea in Seoul, Korea.

The study received funding support from Kangbuk Samsung Hospital.

The study, “The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study,” will be published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

Media Contact
Colleen Williams
[email protected]

Tags: EndocrinologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Microglial CARs Enhance Selective Phagocytosis of Aβ1-42

Microglial CARs Enhance Selective Phagocytosis of Aβ1-42

November 16, 2025

Enhanced CAR-T Cytotoxicity via IDR-Induced Condensation

November 16, 2025

Advancements in Pharmacotherapy for Women’s Sexual Health

November 16, 2025

Decoding Degrons: The Rules of Protein Degradation

November 16, 2025
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    210 shares
    Share 84 Tweet 53
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    201 shares
    Share 80 Tweet 50
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    318 shares
    Share 127 Tweet 80
  • Neurological Impacts of COVID and MIS-C in Children

    89 shares
    Share 36 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microglial CARs Enhance Selective Phagocytosis of Aβ1-42

Oxidative Stress: A Double-Edged Sword in Breast Cancer

Enhanced CAR-T Cytotoxicity via IDR-Induced Condensation

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.